Philippe Van de Perre

20.6k total citations · 1 hit paper
402 papers, 12.2k citations indexed

About

Philippe Van de Perre is a scholar working on Infectious Diseases, Epidemiology and Virology. According to data from OpenAlex, Philippe Van de Perre has authored 402 papers receiving a total of 12.2k indexed citations (citations by other indexed papers that have themselves been cited), including 257 papers in Infectious Diseases, 196 papers in Epidemiology and 129 papers in Virology. Recurrent topics in Philippe Van de Perre's work include HIV/AIDS Research and Interventions (168 papers), HIV Research and Treatment (128 papers) and HIV/AIDS drug development and treatment (44 papers). Philippe Van de Perre is often cited by papers focused on HIV/AIDS Research and Interventions (168 papers), HIV Research and Treatment (128 papers) and HIV/AIDS drug development and treatment (44 papers). Philippe Van de Perre collaborates with scholars based in France, Burkina Faso and United States. Philippe Van de Perre's co-authors include Philippe Lepage, Nicolas Nagot, François Dabis, Philippe Msellati, Édouard Tuaillon, Valériane Leroy, Nicolas Méda, Arlette Simonon, Antoine Serufilira and François Nsengumuremyi and has published in prestigious journals such as New England Journal of Medicine, The Lancet and The EMBO Journal.

In The Last Decade

Philippe Van de Perre

384 papers receiving 11.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

ACQUIRED IMMUNODEFICIENCY SYNDROME IN RWANDA

1984 436 citations Philippe Van de Perre, Philippe Lepage et al. profile →

Peers

Countries citing papers authored by Philippe Van de Perre

Since Specialization

Citations

This map shows the geographic impact of Philippe Van de Perre's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philippe Van de Perre with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philippe Van de Perre more than expected).

Fields of papers citing papers by Philippe Van de Perre

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Philippe Van de Perre. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philippe Van de Perre. The network helps show where Philippe Van de Perre may publish in the future.

Co-authorship network of co-authors of Philippe Van de Perre

This figure shows the co-authorship network connecting the top 25 collaborators of Philippe Van de Perre. A scholar is included among the top collaborators of Philippe Van de Perre based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Philippe Van de Perre. Philippe Van de Perre is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	HIV prevention and undiagnosed infections in children in sub-Saharan Africa 2025 ·The Lancet HIV ·(unknown), Nicolas Méda, Chipepo Kankasa, Roger Shapiro, Theodore Ruel, Ameena Goga, Mwiya Mwiya, (unknown), Thorkild Tylleskär, Anaïs Mennecier, Jean‐Pierre Molès, Philippe Van de Perre, (unknown)	0
2	Long‐term persistence of mitochondrial dysfunctions after viral infections and antiviral therapies: A review of mechanisms involved 2024 ·Journal of Medical Virology ·Laëtitia Gay, Valérie Desquiret‐Dumas, Nicolas Nagot, (unknown), Philippe Van de Perre, Pascal Reynier, Jean‐Pierre Molès	12
3	Leukocyte activation patterns in hospitalized children: comparing SARS-CoV-2, bacterial infections, and inflammatory pathologies 2024 ·Journal of Leukocyte Biology ·(unknown), Anne‐Sophie Bedin, (unknown), (unknown), Caroline Mollévi, Fabrice Malergue, (unknown), Philippe Van de Perre, Édouard Tuaillon, Éric Jeziorski	1
4	Severe Acute Respiratory Syndrome Coronavirus 2 Nucleocapsid Antigen in Urine of Hospitalized Patients With Coronavirus Disease 2019 2022 ·The Journal of Infectious Diseases ·(unknown), Amandine Pisoni, (unknown), Karine Bolloré, Anne‐Sophie Bedin, Alain Makinson, (unknown), (unknown), (unknown), Vincent Le Moing, Philippe Van de Perre, Édouard Tuaillon	6
5	Rapid Diagnostic Test for Hepatitis B Virus Viral Load Based on Recombinase Polymerase Amplification Combined with a Lateral Flow Read-Out 2022 ·Diagnostics ·(unknown), Vincent Foulongne, Philippe Van de Perre, Chantal Fournier‐Wirth, Jean‐Pierre Molès, Jean‐François Cantaloube	9
6	Revisiting Koch's postulate to determine the plausibility of viral transmission by human milk 2021 ·Pediatric Allergy and Immunology ·Philippe Van de Perre, Jean‐Pierre Molès, Nicolas Nagot, Édouard Tuaillon, Pierre‐Emmanuel Ceccaldi, Ameena Goga, Andrew J. Prendergast, Nigel Rollins	10
7	Magnetic field-enhanced agglutination as a readout for rapid serologic assays with human plasma 2021 ·Talanta ·(unknown), Fanny Léon, (unknown), (unknown), Vincent Foulongne, Jean‐François Cantaloube, Philippe Van de Perre, Chantal Fournier‐Wirth, Jean‐Pierre Molès, (unknown)	5
8	Alarmin S100A9 restricts retroviral infection by limiting reverse transcription in human dendritic cells 2021 ·The EMBO Journal ·Ghizlane Maarifi, (unknown), (unknown), Boris Bonaventure, Célia Chamontin, (unknown), Olivier Moncorgé, Marine Tauziet, (unknown), (unknown), Jean‐Pierre Molès, Charles Bodet, Nicolas Lévêque, Antoine Gross, Nathalie J. Arhel, Sébastien Nisole, Philippe Van de Perre, Caroline Goujon, Fabien P. Blanchet	11
9	Diagnostic Performance of a Magnetic Field-Enhanced Agglutination Readout in Detecting Either Viral Genomes or Host Antibodies in Arbovirus Infection 2021 ·Microorganisms ·Fanny Léon, (unknown), (unknown), F. Morvan, Jean‐Jacques Vasseur, (unknown), Vincent Foulongne, Jean‐François Cantaloube, Philippe Van de Perre, Jean‐Pierre Molès, (unknown), Chantal Fournier‐Wirth	2
10	Monocyte CD169 Expression as a Biomarker in the Early Diagnosis of Coronavirus Disease 2019 2020 ·The Journal of Infectious Diseases ·Anne‐Sophie Bedin, Alain Makinson, Marie‐Christine Picot, (unknown), Fabrice Malergue, Amandine Pisoni, (unknown), (unknown), Karine Bolloré, (unknown), David Morquin, (unknown), (unknown), (unknown), (unknown), Caroline Bret, Arnaud Bourdin, (unknown), Philippe Van de Perre, Édouard Tuaillon	43
11	Identifying gaps across the cascade of care for the prevention of HBV mother‐to‐child transmission in Burkina Faso: Findings from the real world 2020 ·Liver International ·(unknown), (unknown), Roger Sombié, Rachel King, Nicolas Nagot, Nicolas Méda, Philippe Van de Perre, Édouard Tuaillon	7
12	MAIT cells, TCR γδ+ cells and ILCs cells in human breast milk and blood from HIV infected and uninfected women 2019 ·Pediatric Allergy and Immunology ·Anne‐Sophie Bedin, Jean‐Pierre Molès, (unknown), Nicolas Nagot, Chipepo Kankasa, Thorkild Tylleskär, (unknown), (unknown), Philippe Van de Perre, Édouard Tuaillon	14
13	Leptospirosis as Cause of Febrile Icteric Illness, Burkina Faso 2018 ·Emerging infectious diseases ·(unknown), Dramane Kania, Albert Sotto, Michel Brun, Mathieu Picardeau, (unknown), Karine Bolloré, Thérèse Kagone, Jacques Traoré, (unknown), Pierre Dujols, Philippe Van de Perre, Nicolas Méda, Édouard Tuaillon	8
14	An Innovative Multiplexed and Flexible Molecular Approach for the Differential Detection of Arboviruses 2018 ·Journal of Molecular Diagnostics ·Fanny Léon, Albert Meyer, (unknown), (unknown), (unknown), (unknown), Yannick Simonin, Sara Salinas, Pierre Gallian, Isabelle Leparc-Goffart, Antoine Biron, Myrielle Dupont‐Rouzeyrol, F. Morvan, Jean‐Jacques Vasseur, (unknown), Philippe Van de Perre, Jean‐François Cantaloube, Chantal Fournier‐Wirth	4
15	[Impaired fertility in women infected with HIV-1. Implications for sentinel serosurveillance]. 2001 ·PubMed ·(unknown), N. Méda, Annabel Desgrées du Loû, Issiaka Sombié, Michel Cartoux, S Tiendrébéogo, Amadou Ouangré, Blami Dao, (unknown), Alphonse Kpozéhouen, Yacouba Nébié, Paulin Fao, Odette Ky‐Zerbo, Philippe Van de Perre, Laurent Mandelbrot, (unknown)	12
16	Infection maternelle par le VIH et paramètres anthropométriques de l’enfant à la naissance au Burkina Faso 1999 ·Cahiers d'études et de recherches francophones / Santé ·Issiaka Sombié, Boubacar Nacro, S Tiendrébéogo, Blami Dao, Michel Cartoux, Nicolas Méda, Odette Ky‐Zerbo, François Dabis, Laurent Mandelbrot, Philippe Van de Perre, (unknown)	1
17	[Routine vaccinations in children and adults infected with HIV]. 1994 ·PubMed ·François Dabis, Philippe Lepage, Philippe Msellati, Philippe Van de Perre, François Nsengumuremyi, Déo-Gratias Hitimana, Joël Ladner, (unknown)	1
18	Pleural effusion, tuberculosis and HIV-1 infection in Kigali, Rwanda 1993 ·AIDS ·J Batungwanayo, Henri Taelman, (unknown), Jos Bogaerts, Abel Kagame, Philippe Van de Perre	48
19	Nosocomial Transmission of HIV in Africa: What Tribute Is Paid to Contaminated Blood Transfusions and Medical Injections? 1988 ·Infection Control and Hospital Epidemiology ·Philippe Lepage, Philippe Van de Perre	16
20	Risk factors for HIV seropositivity in selected urban-based Rwandese adults. 1987 ·PubMed ·Philippe Van de Perre, Michel Caraël, D Nzaramba, Georges Zissis, J Kayihigi, (unknown)	27

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact